Product Description
ED001 is a digital therapeutic for postpartum depression. (Sourced from: https://clinicaltrials.gov/ct2/show/NCT05551195?term=ed001&draw=2&rank=1)
Mechanisms of Action: Device
Novel Mechanism: No
Modality: Device
Route of Administration: N/A
FDA Designation: None *
Approval Status: Not Approved
Approved Countries: None
Approved Indications: None
Known Adverse Events: None
Company: Woebot Health
Company Location:
Company CEO:
Additonal Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Highest Development Phases
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
---|---|---|---|---|---|
WB001-001 | N/A |
Terminated |
Depression, Postpartum |
2023-05-10 |